Size distribution and dye release properties of submicron liposome aerosols

Powder Technology

Volumn 246, Issue , 2013, Pages 530-538

  Chattopadhyay, Saptarshi ^a   Ehrman, Sheryl H ^b   Venkataraman, Chandra ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Encapsulated drug delivery; Lamellarity; Lung deposition; Nanoparticles; Number concentrations

Indexed keywords

AERODYNAMIC DIAMETERS; CONTROLLED RELEASE DRUGS; CONTROLLED RELEASE PROPERTIES; DRUG LOADING CAPACITY; ENCAPSULATED DRUGS; LAMELLARITY; LUNG DEPOSITIONS; NUMBER-CONCENTRATIONS;

AERODYNAMICS; AEROSOLS; DRUG DELIVERY; LIPOSOMES; NANOPARTICLES; POWDERS; SIZE DISTRIBUTION;

SUSPENSIONS (FLUIDS);

DYE; LIPID; LIPOSOME;

AEROSOL; ARTICLE; CHEMICAL COMPOSITION; COLLOID; CONCENTRATION (PARAMETERS); CONTROLLED DRUG RELEASE; HYDRODYNAMICS; LIPOSOMAL DELIVERY; NEBULIZATION; PARTICLE SIZE; POWDER; SUSPENSION;

EID: 84880004748     PISSN: 00325910     EISSN: 1873328X     Source Type: Journal    
DOI: 10.1016/j.powtec.2013.06.013     Document Type: Article

References (27)

1. Miller D.D., Amin M.M., Palmer L.B., Shah A.R., Smaldone G.C. Aerosol delivery and modern mechanical ventilation - in vitro/in vivo evaluation. Am. J. Respir. Cri.t Care Med. Nov 15 2003, 168(10):1205-1209.
2. Chattopadhyay S. Aerosol generation using nanometer liposome suspensions for pulmonary drug delivery applications. J. Lipos. Res. 2013, 1-13. (epub ahead of print).
3. Mansour H.M., Rhee Y.S., Wu X.A. Nanomedicine in pulmonary delivery. Int. J. Nanomedicine 2009, 4:299-319.
4. Farr S.J., Kellaway I.W., Parryjones D.R., Woolfrey S.G. Technetium-99m as a marker of liposomal deposition and clearance in the human-lung. Int. J. Pharm. 1985, 26(3):303-316.
5. Huang Y.Y., Wang C.H. Pulmonary delivery of insulin by liposomal carriers. J. Control. Release 2006, 113(1):9-14.
6. Conley J., Yang H.M., Wilson T., Blasetti K., DiNinno V., Schnell G., et al. Aerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularensis infection in mice. Antimicrob. Agents Chemother. 1997, 41(6):1288-1292.
7. Li Z.L., Zhang Y.L., Wurtz W., Lee J.K., Malinin V.S., Durwas-Krishnan S., et al. Characterization of nebulized liposomal amikacin (Arikace (TM)) as a function of droplet size. J. Aerosol Med. Pulm. Drug Deliv. 2008, 21(3):245-253.
8. Hofmann W. Modelling inhaled particle deposition in the human lung-a review. J. Aerosol Sci. 2011, 42(10):693-724.
9. Dandekar P., Venkataraman C., Mehra A. Pulmonary targeting of nanoparticle drug matrices. J. Aerosol Med.Pulm. Drug Deliv. 2010, 23(6):343-353.
10. Chattopadhyay S., Ehrman S.H., Bellare J., Venkataraman C. Morphology and bilayer integrity of small liposomes during aerosol generation by airjet nebulisation. J. Nanopart. Res. 2012, 14(4):7.
11. Epstein H., Afergan E., Moise T., Richter Y., Rudich Y., Golomb G. Number-concentration of nanoparticles in liposomal and polymeric multiparticulate preparations: empirical and calculation methods. Biomaterials 2006, 27(4):651-659.
12. Mayer L.D., Hope M.J., Cullis P.R. Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim. Biophys. Acta 1986, 858(1):161-168.
13. Monnard P.A., Berclaz N., Conde-Frieboes K., Oberholzer T. Decreased solute entrapment in 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine liposomes prepared by freeze/thaw in the presence of physiological amounts of monovalent salts. Langmuir 1999, 15(22):7504-7509.
14. Hope M.J., Bally M.B., Mayer L.D., Janoff A.S., Cullis P.R. Generation of multilamellar and unilamellar phospholipid-vesicles. Chem. Phys. Lipids 1986, 40(2-4):89-107.
15. Frohlich M., Brecht V., Peschka-Suss R. Parameters influencing the determination of liposome lamellarity by P-31-NMR. Chem. Phys. Lipids 2001, 109(1):103-112.
16. Elhissi A.M.A., Faizi M., Naji W.F., Gill H.S., Taylor K.M.G. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures. Int. J. Pharm. 2007, 334(1-2):62-70.
17. Kleemann E., Schmehl T., Gessler T., Bakowsky U., Kissel T., Seeger W. Iloprost-containing liposomes for aerosol application in pulmonary arterial hypertension: formulation aspects and stability. Pharm. Res. 2007, 24(2):277-287.
18. Washington C. Drug release from microdisperse systems - a critical-review. Int. J. Pharm. 1990, 58(1):1-12.
19. Berger N., Sachse A., Bender J., Schubert R., Brandl M. Filter extrusion of liposomes using different devices: comparison of liposome size, encapsulation efficiency, and process characteristics. Int. J. Pharm. 2001, 223(1-2):55-68.
20. Weiner B.B., Tscharnuter W.W. Uses and abuses of photon-correlation spectroscopy in particle sizing. ACS Symp. Ser. 1987, 332:48-61.
21. Zhu T.F., Szostak J.W. Preparation of large monodisperse vesicles. PLoS One 2009, 4(4).
22. Ehrhardt C., Gaspar M.M., Gobbo O. Generation of liposome aerosols with the Aeroneb Pro and the AeroProbe nebulizers. J. Liposome Res. 2010, 20(1):55-61.
23. Chattopadhyay S., Modesto-Lopez L.B., Venkataraman C., Biswas P. Size distribution and morphology of liposome aerosols generated by two methodologies. Aerosol Sci. Technol. 2010, 44(11):972-982.
24. Egerton R.F. Physical Principles of Electron Microscopy-An Introduction to TEM, SEM, and AEM, Chapter 4 2005, 102. Springer, New York.
25. Parsegian V.A., Fuller N., Rand R.P. Measured work of deformation and repulsion of lecithin bilayers. Proc. Natl. Acad. Sci. U. S. A. 1979, 76(6):2750-2754.
26. Cheow W.S., Hadinoto K. Enhancing encapsulation efficiency of highly water-soluble antibiotic in poly(lactic-co-glycolic acid) nanoparticles: modifications of standard nanoparticle preparation methods. Colloids Surf. A Physicochem. Eng. Asp. 2010, 370(1-3):79-86.
27. Niven R.W., Schreier H. Nebulization of liposomes.1. Effects of lipid-composition. Pharm. Res. 1990, 7(11):1127-1133.